Gabbard Releases Classified DOCS – Departing Bombshell!

For years you were told foreign “U.S. biolabs” were a crazy conspiracy—then Tulsi Gabbard walked out the door at intelligence and dumped the receipts.

Story Snapshot

Declassified files show U.S. taxpayer money backed more than 120 foreign biolabs in over 30 countries, including Ukraine.
Many labs handled dangerous pathogens and, in some cases, gain-of-function research with little outside visibility.
The same claims once dismissed as “Russian propaganda” now sit in official documents on the Director of National Intelligence website.
The records raise hard questions about secrecy, ethics, and who actually controls high‑risk science done in America’s name.

How a “Russian Propaganda” Charge Turned Into an Official Paper Trail

Director of National Intelligence Tulsi Gabbard did not pick a soft last act in office. She ordered a search through intelligence files and then declassified material on a global network of more than 120 U.S.-funded biolabs spread across over 30 countries, including dozens of facilities in Ukraine.^[4] These are not college teaching labs. Intelligence assessments warned at least one U.S.-funded lab in Ukraine likely housed dangerous pathogens and sat within reach of Russian attack or seizure.^[4]

For years, anyone who said “U.S. biolabs in Ukraine” got lumped in with trolls, cranks, or Moscow spin. Media and many politicians brushed off the entire topic as disinformation. Gabbard’s release does something different. The claims now rest on official documents the Office of the Director of National Intelligence chose to declassify and post, not on anonymous chatter or social media threads.^[4]^[6] That shift matters if you care about evidence, not just labels.

What the Declassified Biolab Records Actually Say

The press release from the Director of National Intelligence states the declassified files show “longstanding United States government funding for more than 120 biolabs in over 30 countries.”^[4] The same release notes that many of these labs “are currently or have previously engaged in research using hazardous and highly contagious pathogens,” and that some work “included dangerous gain-of-function research, with very little visibility or oversight.”^[4] That is the intelligence community talking, not a talk-radio host.

Gabbard’s public statement tracks the release. She says evidence about the existence and funding of these labs “had been knowingly withheld” from the American people.^[1]^[3] She ties this push to former President Donald Trump’s order to end federal funding of dangerous gain-of-function research worldwide, and she frames the declassification as part of enforcing that order and restoring accountability.^[3] From a conservative lens, that looks like someone finally saying: the bureaucracy does not get to run global bio projects in the dark with your money.

What the Files Do Not Prove—and Why That Gap Matters

The documents, as described, do not say these facilities were building bioweapons. They show money flows, lab locations, pathogen types, and warnings about safety and security, but not a clean smoking gun that the United States ran an illegal biological weapons program.^[4]^[6] Some of the same labs could be doing normal public‑health work, like tracking outbreaks or testing vaccines, alongside riskier projects. Dual‑use biology muddies the water for anyone trying to draw hard lines.

Coverage and commentary around the release jump quickly to “engineered bioweapons” and sweeping gain‑of‑function claims. Yet the public material so far does not walk through specific experiments, principal investigators, or protocols in detail.^[1]^[3] From a common‑sense standpoint, that gap cuts both ways. It stops critics from screaming “weapon” based only on scary pathogens. But it also blocks defenders from waving everything away as harmless public health. The missing details are exactly what Congress should demand next.

Secrecy, Accountability, and the Intelligence Community’s Credibility Problem

This fight over biolabs sits on top of years of mistrust between everyday Americans and the intelligence agencies that claim to protect them. Gabbard is not just exposing lab funding. She is the same Director of National Intelligence who declassified a House Intelligence report on what she calls the “manufactured Russia hoax” and backed it up with underlying evidence.^[5]^[7] She has built a brand on ripping the veil off past intelligence games that misled both presidents and voters.

No, the comment speculates without evidence. Tulsi Gabbard is outgoing DNI, resigning effective June 30 for her husband’s health. On June 12 she released declassified slides on 120+ US-funded biolabs across 30+ countries, framing it as exposing prior cover-ups and GoF risks tied…

— Grok (@grok) June 14, 2026

Critics argue that because the Office of the Director of National Intelligence is a political post, every release has spin baked in.^[6] That point is fair. Any institution will defend itself. But the answer in a constitutional system is not to shrug and trust secret experts. It is to drag the records into daylight and let lawmakers, outside scientists, and the public read the same pages. If the lab work is above board, full transparency should clear it. If not, the cover‑up is often worse than the crime.

Why This Biolab Story Is Bigger Than Tulsi Gabbard

The deeper issue is whether Washington should fund high‑risk biological work in foreign labs with weak oversight and then hide the details from its own citizens. Gabbard’s new directive orders intelligence agencies to map where these labs are, what pathogens they hold, and what kind of clinical trials they run, citing “ethical, financial, and security concerns” about these projects.^[4] That is a polite way of saying: someone mixed public health branding with dangerous science and murky money streams.

For Americans who value limited government, national sovereignty, and basic prudence, the path forward looks simple. Congress should subpoena the grant files, contracts, and lab inventories. Inspectors general should match every project against past U.S. rules on gain-of-function research. Foreign partners should testify under oath about what actually happened in their facilities. Until that happens, the biolab story will stay where it started—caught between “nothing to see here” and “worst case scenario,” with the truth buried in the files Tulsi Gabbard just pried open.